1 |
American Diabetes Association. 2007. Diagnosis and classification of diabetes mellitus. Diabetes Care 30, S42-S47.
DOI
ScienceOn
|
2 |
Bruun, J. M., Lihn, A. S., Pedersen, S. B. and Richelsen, B. 2005. Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT. J Clin Endocrinol Metab 90, 2282-2289.
DOI
|
3 |
Hotamisligil, G. S., Shargill, N. S. and Spiegelman, B. M. 1993. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259, 87-91.
DOI
ScienceOn
|
4 |
Hotamisligil, G. S. and Spiegelman, B. M. 1994. Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes 43, 1271-1278.
DOI
ScienceOn
|
5 |
Jain, S. K., Kannan, K., Lim, G., Matthews-Greer, J., McVie, R. and Bocchini, J. A., Jr. 2003. Elevated blood interleukin-6 levels in hyperketonemic type 1 diabetic patients and secretion by acetoacetate-treated cultured U937 monocytes. Diabetes Care 26, 2139-2143.
DOI
ScienceOn
|
6 |
Jain, S. K., Kannan, K., Lim, G., McVie, R. and Bocchini, J. A., Jr. 2002. Hyperketonemia increases tumor necrosis factor-alpha secretion in cultured U937 monocytes and Type 1 diabetic patients and is apparently mediated by oxidative stress and cAMP deficiency. Diabetes 51, 2287-2293.
DOI
ScienceOn
|
7 |
Jiang, H., Zhu, H., Chen, X., Peng, Y., Wang, J., Liu, F., Shi, S., Fu, B., Lu, Y., Hong, Q., Feng, Z., Hou, K., Sun, X., Cai, G., Zhang, X. and Xie, Y. 2007. TIMP-1 transgenic mice recover from diabetes induced by multiple low-dose streptozotocin. Diabetes 56, 49-56.
DOI
ScienceOn
|
8 |
Kahn, S. E., Hull, R. L. and Utzschneider, K. M. 2006. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444, 840-846.
DOI
ScienceOn
|
9 |
Kern, P. A., Ranganathan, S., Li, C., Wood, L. and Ranganathan, G. 2001. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 280, E745-751.
|
10 |
Kusakabe, T., Tanioka, H., Ebihara, K., Hirata, M., Miyamoto, L., Miyanaga, F., Hige, H., Aotani, D., Fujisawa, T., Masuzaki, H., Hosoda, K. and Nakao, K. 2009. Beneficial effects of leptin on glycaemic and lipid control in a mouse model of type 2 diabetes with increased adiposity induced by streptozotocin and a high-fat diet. Diabetologia 52, 675-683.
DOI
ScienceOn
|
11 |
Lee, Y. H., Martin, J. M., Maple, R. L., Tharp, W. G. and Pratley, R. E. 2009. Plasma amyloid-beta peptide levels correlate with adipocyte amyloid precursor protein gene expression in obese individuals. Neuroendocrinology 90, 383-390.
DOI
ScienceOn
|
12 |
Lee, Y. H., Nair, S., Rousseau, E., Allison, D. B., Page, G. P., Tataranni, P. A., Bogardus, C. and Permana, P. A. 2005. Microarray profiling of isolated abdominal subcutaneous adipocytes from obese vs non-obese Pima Indians: increased expression of inflammation-related genes. Diabetologia 48, 1776-1783.
DOI
ScienceOn
|
13 |
Lee, Y. H. and Pratley, R. E. 2007. Abdominal obesity and cardiovascular disease risk: the emerging role of the adipocyte. J Cardiopulm Rehabil 27, 2-10.
DOI
|
14 |
Lee, Y. H. and Pratley, R. E. 2005. The evolving role of inflammation in obesity and the metabolic syndrome. Curr Diab Rep 5, 70-75.
DOI
ScienceOn
|
15 |
Li, W., Zhang, M., Gu, J., Meng, Z. J., Zhao, L. C., Zheng, Y. N., Chen, L. and Yang, G. L. 2012. Hypoglycemic effect of protopanaxadiol-type ginsenosides and compound K on Type 2 diabetes mice induced by high-fat diet combining with streptozotocin via suppression of hepatic gluconeogenesis. Fitoterapia 83, 192-198.
DOI
ScienceOn
|
16 |
Parikh, H., Carlsson, E., Chutkow, W. A., Johansson, L. E., Storgaard, H., Poulsen, P., Saxena, R., Ladd, C., Schulze, P. C., Mazzini, M. J., Jensen, C. B., Krook, A., Bjornholm, M., Tornqvist, H., Zierath, J. R., Ridderstrale, M., Altshuler, D., Lee, R. T., Vaag, A., Groop, L. C. and Mootha, V. K. 2007. TXNIP regulates peripheral glucose metabolism in humans. PLoS Med 4, e158.
DOI
|
17 |
Lumeng, C. N., Deyoung, S. M., Bodzin, J. L. and Saltiel, A. R. 2007. Increased inflammatory properties of adipose tissue macrophages recruited during diet-induced obesity. Diabetes 56, 16-23.
DOI
ScienceOn
|
18 |
Lyon, C. J., Law, R. E. and Hsueh, W. A. 2003. Minireview: adiposity, inflammation, and atherogenesis. Endocrinology 144, 2195-2200.
DOI
ScienceOn
|
19 |
Palanivel, R., Vu, V., Park, M., Fang, X. and Sweeney, G. 2008. Differential impact of adipokines derived from primary adipocytes of wild-type versus streptozotocin-induced diabetic rats on glucose and fatty acid metabolism in cardiomyocytes. J Endocrinol 199, 389-397.
DOI
ScienceOn
|
20 |
Pi-Sunyer, F. X. 2002. The obesity epidemic: pathophysiology and consequences of obesity. Obes Res 10, 97S-104S.
DOI
|
21 |
Poucher, S. M., Cheetham, S., Francis, J., Zinker, B., Kirby, M. and Vickers, S. P. 2012. Effects of saxagliptin and sitagliptin on glycaemic control and pancreatic beta-cell mass in a streptozotocin-induced mouse model of type 2 diabetes. Diabetes Obes Metab 14, 918-926.
DOI
ScienceOn
|
22 |
Rajala, M. W. and Scherer, P. E. 2003. Minireview: The adipocyte--at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 144, 3765-3773.
DOI
ScienceOn
|
23 |
Reed, M. J., Meszaros, K., Entes, L. J., Claypool, M. D., Pinkett, J. G., Gadbois, T. M. and Reaven, G. M. 2000. A new rat model of type 2 diabetes: the fat-fed, streptozotocin- treated rat. Metabolism 49, 1390-1394.
DOI
ScienceOn
|
24 |
Ronti, T., Lupattelli, G. and Mannarino, E. 2006. The endocrine function of adipose tissue: an update. Clin Endocrinol (Oxf) 64, 355-365.
|
25 |
Srinivasan, K., Viswanad, B., Asrat, L., Kaul, C. L. and Ramarao, P. 2005. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacol Res 52, 313-320.
DOI
ScienceOn
|
26 |
Sartipy, P. and Loskutoff, D. J. 2003. Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci USA 100, 7265-7270.
DOI
ScienceOn
|
27 |
Schnedl, W. J., Ferber, S., Johnson, J. H. and Newgard, C. B. 1994. STZ transport and cytotoxicity. Specific enhancement in GLUT2-expressing cells. Diabetes 43, 1326-1333.
DOI
ScienceOn
|
28 |
Shoelson, S. E., Lee, J. and Goldfine, A. B. 2006. Inflammation and insulin resistance. J Clin Invest 116, 1793-1801.
DOI
ScienceOn
|
29 |
Tozzo, E., Gnudi, L. and Kahn, B. B. 1997. Amelioration of insulin resistance in streptozotocin diabetic mice by transgenic overexpression of GLUT4 driven by an adipose-specific promoter. Endocrinology 138, 1604-1611.
DOI
ScienceOn
|
30 |
Vozarova, B., Weyer, C., Hanson, K., Tataranni, P. A., Bogardus, C. and Pratley, R. E. 2001. Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes Res 9, 414-417.
DOI
ScienceOn
|
31 |
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L. and Ferrante, A. W., Jr. 2003. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112, 1796-1808.
DOI
|
32 |
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A. and Chen, H. 2003. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112, 1821-1830.
DOI
ScienceOn
|
33 |
Yamamoto, H., Uchigata, Y. and Okamoto, H. 1981. Streptozotocin and alloxan induce DNA strand breaks and poly (ADP-ribose) synthetase in pancreatic islets. Nature 294, 284-286.
DOI
ScienceOn
|
34 |
Kershaw, E. E. and Flier, J. S. 2004. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89, 2548-2556.
DOI
ScienceOn
|